DK1778271T3 - Peptid til behandling af herpesvirusinfektioner - Google Patents

Peptid til behandling af herpesvirusinfektioner

Info

Publication number
DK1778271T3
DK1778271T3 DK05786951T DK05786951T DK1778271T3 DK 1778271 T3 DK1778271 T3 DK 1778271T3 DK 05786951 T DK05786951 T DK 05786951T DK 05786951 T DK05786951 T DK 05786951T DK 1778271 T3 DK1778271 T3 DK 1778271T3
Authority
DK
Denmark
Prior art keywords
peptide
treatment
herpes virus
virus infections
vcvlahhfgkeftppvqaayqkvvagvanalahkyh
Prior art date
Application number
DK05786951T
Other languages
English (en)
Inventor
Wolf-Georg Forssmann
Frank Kirchhoff
Ludger Staendker
Jan Muench
Original Assignee
Ipf Pharmaceuticals Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipf Pharmaceuticals Gmbh filed Critical Ipf Pharmaceuticals Gmbh
Application granted granted Critical
Publication of DK1778271T3 publication Critical patent/DK1778271T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/017—Hydrolysed proteins; Derivatives thereof from animals from blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
DK05786951T 2004-08-18 2005-08-16 Peptid til behandling af herpesvirusinfektioner DK1778271T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60231304P 2004-08-18 2004-08-18
EP04019552 2004-08-18
PCT/EP2005/054028 WO2006018431A2 (en) 2004-08-18 2005-08-16 Peptides for the treatment of herpes virus infections

Publications (1)

Publication Number Publication Date
DK1778271T3 true DK1778271T3 (da) 2009-02-16

Family

ID=34926208

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05786951T DK1778271T3 (da) 2004-08-18 2005-08-16 Peptid til behandling af herpesvirusinfektioner

Country Status (7)

Country Link
US (1) US7741287B2 (da)
EP (1) EP1778271B1 (da)
JP (1) JP5101280B2 (da)
AT (1) ATE411812T1 (da)
CA (1) CA2558289C (da)
DK (1) DK1778271T3 (da)
WO (1) WO2006018431A2 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602005010590D1 (de) * 2004-08-18 2008-12-04 Ipf Pharmaceuticals Gmbh Peptide zur behandlung von infektionen mit dem herpes-virus
IT1395137B1 (it) 2009-08-05 2012-09-05 Spider Biotech S R L Nuovi peptidi antipatogeni
ES2444299B1 (es) 2012-08-23 2014-12-12 Nutrición Técnica Deportiva, S.L. Uso de un hidrolizado de caseina como agente antiherpético
EP2789343A1 (en) * 2013-04-11 2014-10-15 Clinique La Prairie Novel hemoglobin-derived peptide based pharmaceutical compositions
JP6464507B2 (ja) * 2014-12-24 2019-02-06 国立大学法人秋田大学 抗ウイルス剤、および抗菌剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS649997A (en) 1987-07-02 1989-01-13 Toray Industries Serine protease inhibitor
US5922854A (en) * 1991-06-14 1999-07-13 Kumar; Ramesh Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
WO1994022915A1 (en) * 1993-03-31 1994-10-13 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6610654B2 (en) * 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
JP2000516455A (ja) * 1996-08-02 2000-12-12 バクスター バイオテック テクノロジー エス．アー．エール．エル． ヘモグロビンにおけるβダイマー形成を制御する方法
CA2309554A1 (en) * 1997-10-08 1999-04-15 Theragem, Inc. Mammalian-derived peptides for the treatment of microbial infection
WO2001094386A2 (de) 2000-06-08 2001-12-13 Ipf Pharmaceuticals Gmbh Verfahren zur gewinnung und anwendung von antibiotisch wirksamen peptiden zur behandlung von infektionskrankheiten
GB0125793D0 (en) 2001-10-26 2001-12-19 Panzeri Ezio Method

Also Published As

Publication number Publication date
EP1778271B1 (en) 2008-10-22
EP1778271A2 (en) 2007-05-02
JP5101280B2 (ja) 2012-12-19
CA2558289A1 (en) 2006-02-23
ATE411812T1 (de) 2008-11-15
WO2006018431A2 (en) 2006-02-23
CA2558289C (en) 2018-05-15
JP2008509969A (ja) 2008-04-03
US20080312144A1 (en) 2008-12-18
WO2006018431A3 (en) 2006-06-08
US7741287B2 (en) 2010-06-22

Similar Documents

Publication Publication Date Title
ES2563646T3 (es) Composiciones y métodos relacionados con variantes de la proteína A (SpA)
MXPA03000626A (es) Nuevos peptidos como inhibidores de ns3-serina proteasa del virus de la hepatitis c.
CY1112267T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης ns3-σερινης του ιου ηπατιτιδας c
WO2002008256A3 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
DE602005020165D1 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
WO2002008251A3 (en) Peptides as ns3-serine protease inhibitors of hepatitis c virus
NO20063026L (no) Antistoffer
CY1114893T1 (el) Παραγωγη ανθρωπινης γλυκοσερεμπροσιδασης υψηλης μαννοζης σε φυτικη καλλιεργεια
PE20190420A1 (es) Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas
HK1088840A1 (en) Stable analogs of glp-1 glp-1
WO2009147248A3 (en) Amino acid sequences directed against envelope proteins of a virus and polypeptides comprising the same for the treatment of viral diseases
ECSP093601A (es) Proteínas derivadas del virus del síndrome de mancha blanca y sus usos
DK1349944T3 (da) Latensassocieret peptid af TGF-beta til at bibringe farmaceutisk aktive proteiner latens
WO2005007078A3 (en) Method of inhibiting human metapneumovirus and human coronavirus in the prevention and treatment of severe acute respiratory syndrome (sars)
PE20110394A1 (es) Virus sincitial respiratorio vivo atenuado
WO2005002526A3 (en) Method and compositions for treatment of viral infections
DK1778271T3 (da) Peptid til behandling af herpesvirusinfektioner
CY1114724T1 (el) Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
RU2005123050A (ru) Супер-антигенные фьюжн-белки и их использование
DK1501936T3 (da) Familie af cytokin-proteiner
DE60332425D1 (de) 5t4-antigen-peptidepitope der mhc klasse ii
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
DK1417222T3 (da) Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop
WO2006109174A3 (en) Hiv vaccine comprising a glycoprotein 120 signal sequence with no more than one positively charged amino acid